nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C8—Nilutamide—prostate cancer	0.0837	0.129	CbGbCtD
Secobarbital—CYP2C8—Abiraterone—prostate cancer	0.0693	0.107	CbGbCtD
Secobarbital—CYP2C9—Bicalutamide—prostate cancer	0.0583	0.0899	CbGbCtD
Secobarbital—CYP2C9—Nilutamide—prostate cancer	0.0583	0.0899	CbGbCtD
Secobarbital—CYP1A2—Flutamide—prostate cancer	0.0537	0.0826	CbGbCtD
Secobarbital—CYP2C8—Cabazitaxel—prostate cancer	0.0513	0.079	CbGbCtD
Secobarbital—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0447	0.0688	CbGbCtD
Secobarbital—CYP1A2—Estrone—prostate cancer	0.0388	0.0597	CbGbCtD
Secobarbital—CYP2C9—Estrone—prostate cancer	0.035	0.0538	CbGbCtD
Secobarbital—CYP2C8—Estradiol—prostate cancer	0.0288	0.0443	CbGbCtD
Secobarbital—CYP2C9—Capecitabine—prostate cancer	0.0265	0.0408	CbGbCtD
Secobarbital—CYP1A2—Conjugated Estrogens—prostate cancer	0.0254	0.0391	CbGbCtD
Secobarbital—CYP1A2—Estradiol—prostate cancer	0.0223	0.0343	CbGbCtD
Secobarbital—CYP2C9—Estradiol—prostate cancer	0.0201	0.0309	CbGbCtD
Secobarbital—CYP2C8—Etoposide—prostate cancer	0.0188	0.0289	CbGbCtD
Secobarbital—CYP1A2—Etoposide—prostate cancer	0.0145	0.0224	CbGbCtD
Secobarbital—Body temperature increased—Cabazitaxel—prostate cancer	0.000752	0.0043	CcSEcCtD
Secobarbital—Dizziness—Nilutamide—prostate cancer	0.000747	0.00427	CcSEcCtD
Secobarbital—Dizziness—Flutamide—prostate cancer	0.000744	0.00425	CcSEcCtD
Secobarbital—Hypersensitivity—Degarelix—prostate cancer	0.000744	0.00425	CcSEcCtD
Secobarbital—Somnolence—Bicalutamide—prostate cancer	0.000725	0.00414	CcSEcCtD
Secobarbital—Nausea—Estrone—prostate cancer	0.000723	0.00413	CcSEcCtD
Secobarbital—Vomiting—Nilutamide—prostate cancer	0.000719	0.00411	CcSEcCtD
Secobarbital—Anxiety—Ethinyl Estradiol—prostate cancer	0.000717	0.0041	CcSEcCtD
Secobarbital—Vomiting—Flutamide—prostate cancer	0.000715	0.00409	CcSEcCtD
Secobarbital—Rash—Nilutamide—prostate cancer	0.000713	0.00407	CcSEcCtD
Secobarbital—Dermatitis—Nilutamide—prostate cancer	0.000712	0.00407	CcSEcCtD
Secobarbital—Rash—Flutamide—prostate cancer	0.000709	0.00405	CcSEcCtD
Secobarbital—Dermatitis—Flutamide—prostate cancer	0.000709	0.00405	CcSEcCtD
Secobarbital—Headache—Nilutamide—prostate cancer	0.000708	0.00405	CcSEcCtD
Secobarbital—Headache—Flutamide—prostate cancer	0.000705	0.00403	CcSEcCtD
Secobarbital—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000702	0.00401	CcSEcCtD
Secobarbital—Hypersensitivity—Cabazitaxel—prostate cancer	0.000701	0.004	CcSEcCtD
Secobarbital—Constipation—Bicalutamide—prostate cancer	0.000698	0.00399	CcSEcCtD
Secobarbital—Mental disability—Capecitabine—prostate cancer	0.000682	0.0039	CcSEcCtD
Secobarbital—Tension—Goserelin—prostate cancer	0.000682	0.0039	CcSEcCtD
Secobarbital—Tension—Conjugated Estrogens—prostate cancer	0.000676	0.00386	CcSEcCtD
Secobarbital—Nervousness—Goserelin—prostate cancer	0.000675	0.00386	CcSEcCtD
Secobarbital—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000675	0.00386	CcSEcCtD
Secobarbital—Feeling abnormal—Bicalutamide—prostate cancer	0.000672	0.00384	CcSEcCtD
Secobarbital—Nausea—Nilutamide—prostate cancer	0.000671	0.00384	CcSEcCtD
Secobarbital—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00067	0.00383	CcSEcCtD
Secobarbital—Nervousness—Conjugated Estrogens—prostate cancer	0.000669	0.00382	CcSEcCtD
Secobarbital—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000669	0.00382	CcSEcCtD
Secobarbital—Nausea—Flutamide—prostate cancer	0.000668	0.00382	CcSEcCtD
Secobarbital—Dizziness—Degarelix—prostate cancer	0.000668	0.00381	CcSEcCtD
Secobarbital—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000665	0.0038	CcSEcCtD
Secobarbital—Liver injury—Epirubicin—prostate cancer	0.000651	0.00372	CcSEcCtD
Secobarbital—Body temperature increased—Bicalutamide—prostate cancer	0.000645	0.00369	CcSEcCtD
Secobarbital—Vomiting—Degarelix—prostate cancer	0.000642	0.00367	CcSEcCtD
Secobarbital—Rash—Degarelix—prostate cancer	0.000637	0.00364	CcSEcCtD
Secobarbital—Dermatitis—Degarelix—prostate cancer	0.000636	0.00363	CcSEcCtD
Secobarbital—Headache—Degarelix—prostate cancer	0.000632	0.00361	CcSEcCtD
Secobarbital—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000631	0.0036	CcSEcCtD
Secobarbital—Angioedema—Conjugated Estrogens—prostate cancer	0.000629	0.0036	CcSEcCtD
Secobarbital—Dizziness—Cabazitaxel—prostate cancer	0.000629	0.00359	CcSEcCtD
Secobarbital—Syncope—Conjugated Estrogens—prostate cancer	0.000618	0.00353	CcSEcCtD
Secobarbital—Hyperkinesia—Prednisone—prostate cancer	0.000611	0.00349	CcSEcCtD
Secobarbital—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.000605	0.00346	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Capecitabine—prostate cancer	0.000605	0.00346	CcSEcCtD
Secobarbital—Vomiting—Cabazitaxel—prostate cancer	0.000605	0.00346	CcSEcCtD
Secobarbital—Liver injury—Doxorubicin—prostate cancer	0.000602	0.00344	CcSEcCtD
Secobarbital—Hypersensitivity—Bicalutamide—prostate cancer	0.000601	0.00343	CcSEcCtD
Secobarbital—Bradycardia—Mitoxantrone—prostate cancer	0.000601	0.00343	CcSEcCtD
Secobarbital—Nausea—Degarelix—prostate cancer	0.0006	0.00343	CcSEcCtD
Secobarbital—Thinking abnormal—Epirubicin—prostate cancer	0.000598	0.00342	CcSEcCtD
Secobarbital—Headache—Cabazitaxel—prostate cancer	0.000596	0.0034	CcSEcCtD
Secobarbital—Anxiety—Goserelin—prostate cancer	0.00059	0.00337	CcSEcCtD
Secobarbital—Constipation—Ethinyl Estradiol—prostate cancer	0.00059	0.00337	CcSEcCtD
Secobarbital—Anxiety—Conjugated Estrogens—prostate cancer	0.000584	0.00334	CcSEcCtD
Secobarbital—Amobarbital—CYP2A6—prostate cancer	0.000573	0.115	CrCbGaD
Secobarbital—Confusional state—Goserelin—prostate cancer	0.000572	0.00327	CcSEcCtD
Secobarbital—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000568	0.00325	CcSEcCtD
Secobarbital—Phenobarbital—CYP2C18—prostate cancer	0.000565	0.114	CrCbGaD
Secobarbital—Nausea—Cabazitaxel—prostate cancer	0.000565	0.00323	CcSEcCtD
Secobarbital—Shock—Goserelin—prostate cancer	0.000558	0.00319	CcSEcCtD
Secobarbital—Ataxia—Docetaxel—prostate cancer	0.000554	0.00317	CcSEcCtD
Secobarbital—Thinking abnormal—Doxorubicin—prostate cancer	0.000554	0.00316	CcSEcCtD
Secobarbital—Shock—Conjugated Estrogens—prostate cancer	0.000553	0.00316	CcSEcCtD
Secobarbital—Hepatocellular injury—Epirubicin—prostate cancer	0.000548	0.00313	CcSEcCtD
Secobarbital—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000545	0.00312	CcSEcCtD
Secobarbital—Injection site reaction—Epirubicin—prostate cancer	0.000545	0.00311	CcSEcCtD
Secobarbital—Tension—Estradiol—prostate cancer	0.000541	0.00309	CcSEcCtD
Secobarbital—Dizziness—Bicalutamide—prostate cancer	0.00054	0.00308	CcSEcCtD
Secobarbital—Ataxia—Capecitabine—prostate cancer	0.000537	0.00307	CcSEcCtD
Secobarbital—Nervousness—Estradiol—prostate cancer	0.000535	0.00306	CcSEcCtD
Secobarbital—Hypotension—Goserelin—prostate cancer	0.00053	0.00303	CcSEcCtD
Secobarbital—Hypotension—Conjugated Estrogens—prostate cancer	0.000525	0.003	CcSEcCtD
Secobarbital—Vomiting—Bicalutamide—prostate cancer	0.000519	0.00296	CcSEcCtD
Secobarbital—Rash—Bicalutamide—prostate cancer	0.000514	0.00294	CcSEcCtD
Secobarbital—Dermatitis—Bicalutamide—prostate cancer	0.000514	0.00294	CcSEcCtD
Secobarbital—Headache—Bicalutamide—prostate cancer	0.000511	0.00292	CcSEcCtD
Secobarbital—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000508	0.0029	CcSEcCtD
Secobarbital—Hepatocellular injury—Doxorubicin—prostate cancer	0.000507	0.0029	CcSEcCtD
Secobarbital—Agitation—Estradiol—prostate cancer	0.000507	0.00289	CcSEcCtD
Secobarbital—Somnolence—Goserelin—prostate cancer	0.000505	0.00288	CcSEcCtD
Secobarbital—Injection site reaction—Doxorubicin—prostate cancer	0.000504	0.00288	CcSEcCtD
Secobarbital—Angioedema—Estradiol—prostate cancer	0.000504	0.00288	CcSEcCtD
Secobarbital—Somnolence—Conjugated Estrogens—prostate cancer	0.0005	0.00286	CcSEcCtD
Secobarbital—Syncope—Estradiol—prostate cancer	0.000494	0.00283	CcSEcCtD
Secobarbital—Constipation—Goserelin—prostate cancer	0.000485	0.00277	CcSEcCtD
Secobarbital—Nausea—Bicalutamide—prostate cancer	0.000485	0.00277	CcSEcCtD
Secobarbital—Loss of consciousness—Estradiol—prostate cancer	0.000485	0.00277	CcSEcCtD
Secobarbital—Pentobarbital—CYP2A6—prostate cancer	0.000481	0.0969	CrCbGaD
Secobarbital—Constipation—Conjugated Estrogens—prostate cancer	0.000481	0.00275	CcSEcCtD
Secobarbital—Mental disability—Epirubicin—prostate cancer	0.000475	0.00272	CcSEcCtD
Secobarbital—Anxiety—Estradiol—prostate cancer	0.000468	0.00267	CcSEcCtD
Secobarbital—Feeling abnormal—Goserelin—prostate cancer	0.000468	0.00267	CcSEcCtD
Secobarbital—Phenobarbital—CYP1B1—prostate cancer	0.000468	0.0941	CrCbGaD
Secobarbital—Dizziness—Ethinyl Estradiol—prostate cancer	0.000456	0.00261	CcSEcCtD
Secobarbital—Confusional state—Estradiol—prostate cancer	0.000454	0.00259	CcSEcCtD
Secobarbital—Body temperature increased—Goserelin—prostate cancer	0.000449	0.00256	CcSEcCtD
Secobarbital—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000444	0.00254	CcSEcCtD
Secobarbital—Shock—Estradiol—prostate cancer	0.000443	0.00253	CcSEcCtD
Secobarbital—Mental disability—Doxorubicin—prostate cancer	0.00044	0.00251	CcSEcCtD
Secobarbital—Vomiting—Ethinyl Estradiol—prostate cancer	0.000438	0.00251	CcSEcCtD
Secobarbital—Anxiety—Mitoxantrone—prostate cancer	0.000436	0.00249	CcSEcCtD
Secobarbital—Rash—Ethinyl Estradiol—prostate cancer	0.000435	0.00248	CcSEcCtD
Secobarbital—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000434	0.00248	CcSEcCtD
Secobarbital—Headache—Ethinyl Estradiol—prostate cancer	0.000432	0.00247	CcSEcCtD
Secobarbital—Confusional state—Mitoxantrone—prostate cancer	0.000423	0.00242	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000421	0.00241	CcSEcCtD
Secobarbital—Hypersensitivity—Goserelin—prostate cancer	0.000418	0.00239	CcSEcCtD
Secobarbital—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000414	0.00237	CcSEcCtD
Secobarbital—Shock—Mitoxantrone—prostate cancer	0.000412	0.00236	CcSEcCtD
Secobarbital—Thiopental—CYP2E1—prostate cancer	0.000412	0.0829	CrCbGaD
Secobarbital—Nausea—Ethinyl Estradiol—prostate cancer	0.00041	0.00234	CcSEcCtD
Secobarbital—Bradycardia—Capecitabine—prostate cancer	0.000402	0.0023	CcSEcCtD
Secobarbital—Somnolence—Estradiol—prostate cancer	0.0004	0.00229	CcSEcCtD
Secobarbital—Hypotension—Mitoxantrone—prostate cancer	0.000392	0.00224	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.00039	0.00223	CcSEcCtD
Secobarbital—Constipation—Estradiol—prostate cancer	0.000385	0.0022	CcSEcCtD
Secobarbital—Loss of consciousness—Etoposide—prostate cancer	0.000376	0.00215	CcSEcCtD
Secobarbital—Dizziness—Goserelin—prostate cancer	0.000375	0.00214	CcSEcCtD
Secobarbital—Ataxia—Epirubicin—prostate cancer	0.000374	0.00214	CcSEcCtD
Secobarbital—Somnolence—Mitoxantrone—prostate cancer	0.000373	0.00213	CcSEcCtD
Secobarbital—Phenobarbital—CYP3A5—prostate cancer	0.000372	0.075	CrCbGaD
Secobarbital—Dizziness—Conjugated Estrogens—prostate cancer	0.000372	0.00212	CcSEcCtD
Secobarbital—Feeling abnormal—Estradiol—prostate cancer	0.000371	0.00212	CcSEcCtD
Secobarbital—Vomiting—Goserelin—prostate cancer	0.000361	0.00206	CcSEcCtD
Secobarbital—Phenobarbital—CYP2A6—prostate cancer	0.00036	0.0726	CrCbGaD
Secobarbital—Constipation—Mitoxantrone—prostate cancer	0.000358	0.00205	CcSEcCtD
Secobarbital—Bradycardia—Prednisone—prostate cancer	0.000358	0.00205	CcSEcCtD
Secobarbital—Rash—Goserelin—prostate cancer	0.000358	0.00204	CcSEcCtD
Secobarbital—Dermatitis—Goserelin—prostate cancer	0.000358	0.00204	CcSEcCtD
Secobarbital—Vomiting—Conjugated Estrogens—prostate cancer	0.000357	0.00204	CcSEcCtD
Secobarbital—Body temperature increased—Estradiol—prostate cancer	0.000356	0.00203	CcSEcCtD
Secobarbital—Headache—Goserelin—prostate cancer	0.000356	0.00203	CcSEcCtD
Secobarbital—Rash—Conjugated Estrogens—prostate cancer	0.000354	0.00203	CcSEcCtD
Secobarbital—Dermatitis—Conjugated Estrogens—prostate cancer	0.000354	0.00202	CcSEcCtD
Secobarbital—Headache—Conjugated Estrogens—prostate cancer	0.000352	0.00201	CcSEcCtD
Secobarbital—Confusional state—Etoposide—prostate cancer	0.000352	0.00201	CcSEcCtD
Secobarbital—Hallucination—Prednisone—prostate cancer	0.00035	0.002	CcSEcCtD
Secobarbital—Ataxia—Doxorubicin—prostate cancer	0.000346	0.00198	CcSEcCtD
Secobarbital—Feeling abnormal—Mitoxantrone—prostate cancer	0.000345	0.00197	CcSEcCtD
Secobarbital—Pentobarbital—CYP2C19—prostate cancer	0.000338	0.0681	CrCbGaD
Secobarbital—Nausea—Goserelin—prostate cancer	0.000337	0.00193	CcSEcCtD
Secobarbital—Nausea—Conjugated Estrogens—prostate cancer	0.000334	0.00191	CcSEcCtD
Secobarbital—Hypersensitivity—Estradiol—prostate cancer	0.000331	0.00189	CcSEcCtD
Secobarbital—Body temperature increased—Mitoxantrone—prostate cancer	0.000331	0.00189	CcSEcCtD
Secobarbital—Hypotension—Etoposide—prostate cancer	0.000326	0.00186	CcSEcCtD
Secobarbital—Syncope—Docetaxel—prostate cancer	0.000318	0.00182	CcSEcCtD
Secobarbital—Loss of consciousness—Docetaxel—prostate cancer	0.000312	0.00178	CcSEcCtD
Secobarbital—Somnolence—Etoposide—prostate cancer	0.00031	0.00177	CcSEcCtD
Secobarbital—Hypersensitivity—Mitoxantrone—prostate cancer	0.000309	0.00176	CcSEcCtD
Secobarbital—Syncope—Capecitabine—prostate cancer	0.000308	0.00176	CcSEcCtD
Secobarbital—Loss of consciousness—Capecitabine—prostate cancer	0.000302	0.00173	CcSEcCtD
Secobarbital—Constipation—Etoposide—prostate cancer	0.000298	0.0017	CcSEcCtD
Secobarbital—Dizziness—Estradiol—prostate cancer	0.000298	0.0017	CcSEcCtD
Secobarbital—Confusional state—Docetaxel—prostate cancer	0.000292	0.00167	CcSEcCtD
Secobarbital—Anxiety—Capecitabine—prostate cancer	0.000292	0.00167	CcSEcCtD
Secobarbital—Feeling abnormal—Etoposide—prostate cancer	0.000287	0.00164	CcSEcCtD
Secobarbital—Vomiting—Estradiol—prostate cancer	0.000286	0.00163	CcSEcCtD
Secobarbital—Shock—Docetaxel—prostate cancer	0.000285	0.00163	CcSEcCtD
Secobarbital—Rash—Estradiol—prostate cancer	0.000284	0.00162	CcSEcCtD
Secobarbital—Dermatitis—Estradiol—prostate cancer	0.000283	0.00162	CcSEcCtD
Secobarbital—Confusional state—Capecitabine—prostate cancer	0.000283	0.00162	CcSEcCtD
Secobarbital—Headache—Estradiol—prostate cancer	0.000282	0.00161	CcSEcCtD
Secobarbital—Agitation—Prednisone—prostate cancer	0.000281	0.00161	CcSEcCtD
Secobarbital—Bradycardia—Epirubicin—prostate cancer	0.00028	0.0016	CcSEcCtD
Secobarbital—Angioedema—Prednisone—prostate cancer	0.00028	0.0016	CcSEcCtD
Secobarbital—Shock—Capecitabine—prostate cancer	0.000276	0.00158	CcSEcCtD
Secobarbital—Body temperature increased—Etoposide—prostate cancer	0.000276	0.00158	CcSEcCtD
Secobarbital—Syncope—Prednisone—prostate cancer	0.000275	0.00157	CcSEcCtD
Secobarbital—Hypotension—Docetaxel—prostate cancer	0.000271	0.00155	CcSEcCtD
Secobarbital—Loss of consciousness—Prednisone—prostate cancer	0.000269	0.00154	CcSEcCtD
Secobarbital—Nausea—Estradiol—prostate cancer	0.000267	0.00153	CcSEcCtD
Secobarbital—Vomiting—Mitoxantrone—prostate cancer	0.000267	0.00152	CcSEcCtD
Secobarbital—Rash—Mitoxantrone—prostate cancer	0.000264	0.00151	CcSEcCtD
Secobarbital—Dermatitis—Mitoxantrone—prostate cancer	0.000264	0.00151	CcSEcCtD
Secobarbital—Headache—Mitoxantrone—prostate cancer	0.000263	0.0015	CcSEcCtD
Secobarbital—Hypotension—Capecitabine—prostate cancer	0.000262	0.0015	CcSEcCtD
Secobarbital—Anxiety—Prednisone—prostate cancer	0.00026	0.00148	CcSEcCtD
Secobarbital—Thiopental—CYP3A4—prostate cancer	0.000259	0.0522	CrCbGaD
Secobarbital—Bradycardia—Doxorubicin—prostate cancer	0.000259	0.00148	CcSEcCtD
Secobarbital—Somnolence—Docetaxel—prostate cancer	0.000258	0.00147	CcSEcCtD
Secobarbital—Hypersensitivity—Etoposide—prostate cancer	0.000257	0.00147	CcSEcCtD
Secobarbital—Phenobarbital—CYP2E1—prostate cancer	0.000256	0.0515	CrCbGaD
Secobarbital—Phenobarbital—CYP2C19—prostate cancer	0.000253	0.051	CrCbGaD
Secobarbital—Phenobarbital—CYP1A1—prostate cancer	0.000253	0.0508	CrCbGaD
Secobarbital—Nausea—Mitoxantrone—prostate cancer	0.000249	0.00142	CcSEcCtD
Secobarbital—Constipation—Docetaxel—prostate cancer	0.000248	0.00142	CcSEcCtD
Secobarbital—Shock—Prednisone—prostate cancer	0.000246	0.00141	CcSEcCtD
Secobarbital—Constipation—Capecitabine—prostate cancer	0.00024	0.00137	CcSEcCtD
Secobarbital—Feeling abnormal—Docetaxel—prostate cancer	0.000239	0.00136	CcSEcCtD
Secobarbital—Tension—Epirubicin—prostate cancer	0.000235	0.00134	CcSEcCtD
Secobarbital—Nervousness—Epirubicin—prostate cancer	0.000233	0.00133	CcSEcCtD
Secobarbital—Feeling abnormal—Capecitabine—prostate cancer	0.000231	0.00132	CcSEcCtD
Secobarbital—Dizziness—Etoposide—prostate cancer	0.000231	0.00132	CcSEcCtD
Secobarbital—Body temperature increased—Docetaxel—prostate cancer	0.000229	0.00131	CcSEcCtD
Secobarbital—Body temperature increased—Capecitabine—prostate cancer	0.000222	0.00127	CcSEcCtD
Secobarbital—Vomiting—Etoposide—prostate cancer	0.000222	0.00127	CcSEcCtD
Secobarbital—Agitation—Epirubicin—prostate cancer	0.00022	0.00126	CcSEcCtD
Secobarbital—Rash—Etoposide—prostate cancer	0.00022	0.00126	CcSEcCtD
Secobarbital—Dermatitis—Etoposide—prostate cancer	0.00022	0.00126	CcSEcCtD
Secobarbital—Headache—Etoposide—prostate cancer	0.000218	0.00125	CcSEcCtD
Secobarbital—Tension—Doxorubicin—prostate cancer	0.000217	0.00124	CcSEcCtD
Secobarbital—Nervousness—Doxorubicin—prostate cancer	0.000215	0.00123	CcSEcCtD
Secobarbital—Pentobarbital—CYP3A4—prostate cancer	0.000215	0.0433	CrCbGaD
Secobarbital—Syncope—Epirubicin—prostate cancer	0.000215	0.00123	CcSEcCtD
Secobarbital—Constipation—Prednisone—prostate cancer	0.000214	0.00122	CcSEcCtD
Secobarbital—Hypersensitivity—Docetaxel—prostate cancer	0.000214	0.00122	CcSEcCtD
Secobarbital—Loss of consciousness—Epirubicin—prostate cancer	0.000211	0.0012	CcSEcCtD
Secobarbital—Nausea—Etoposide—prostate cancer	0.000207	0.00118	CcSEcCtD
Secobarbital—Hypersensitivity—Capecitabine—prostate cancer	0.000207	0.00118	CcSEcCtD
Secobarbital—Feeling abnormal—Prednisone—prostate cancer	0.000206	0.00118	CcSEcCtD
Secobarbital—Agitation—Doxorubicin—prostate cancer	0.000204	0.00116	CcSEcCtD
Secobarbital—Anxiety—Epirubicin—prostate cancer	0.000203	0.00116	CcSEcCtD
Secobarbital—Syncope—Doxorubicin—prostate cancer	0.000199	0.00114	CcSEcCtD
Secobarbital—Body temperature increased—Prednisone—prostate cancer	0.000198	0.00113	CcSEcCtD
Secobarbital—Confusional state—Epirubicin—prostate cancer	0.000197	0.00113	CcSEcCtD
Secobarbital—Loss of consciousness—Doxorubicin—prostate cancer	0.000195	0.00111	CcSEcCtD
Secobarbital—Shock—Epirubicin—prostate cancer	0.000192	0.0011	CcSEcCtD
Secobarbital—Dizziness—Docetaxel—prostate cancer	0.000192	0.0011	CcSEcCtD
Secobarbital—Anxiety—Doxorubicin—prostate cancer	0.000188	0.00107	CcSEcCtD
Secobarbital—Dizziness—Capecitabine—prostate cancer	0.000186	0.00106	CcSEcCtD
Secobarbital—Vomiting—Docetaxel—prostate cancer	0.000184	0.00105	CcSEcCtD
Secobarbital—Hypersensitivity—Prednisone—prostate cancer	0.000184	0.00105	CcSEcCtD
Secobarbital—Rash—Docetaxel—prostate cancer	0.000183	0.00104	CcSEcCtD
Secobarbital—Hypotension—Epirubicin—prostate cancer	0.000183	0.00104	CcSEcCtD
Secobarbital—Dermatitis—Docetaxel—prostate cancer	0.000183	0.00104	CcSEcCtD
Secobarbital—Confusional state—Doxorubicin—prostate cancer	0.000182	0.00104	CcSEcCtD
Secobarbital—Headache—Docetaxel—prostate cancer	0.000182	0.00104	CcSEcCtD
Secobarbital—Vomiting—Capecitabine—prostate cancer	0.000178	0.00102	CcSEcCtD
Secobarbital—Shock—Doxorubicin—prostate cancer	0.000178	0.00102	CcSEcCtD
Secobarbital—Rash—Capecitabine—prostate cancer	0.000177	0.00101	CcSEcCtD
Secobarbital—Dermatitis—Capecitabine—prostate cancer	0.000177	0.00101	CcSEcCtD
Secobarbital—Headache—Capecitabine—prostate cancer	0.000176	0.001	CcSEcCtD
Secobarbital—Somnolence—Epirubicin—prostate cancer	0.000174	0.000993	CcSEcCtD
Secobarbital—Nausea—Docetaxel—prostate cancer	0.000172	0.000984	CcSEcCtD
Secobarbital—Hypotension—Doxorubicin—prostate cancer	0.000169	0.000966	CcSEcCtD
Secobarbital—Constipation—Epirubicin—prostate cancer	0.000167	0.000955	CcSEcCtD
Secobarbital—Nausea—Capecitabine—prostate cancer	0.000167	0.000952	CcSEcCtD
Secobarbital—Dizziness—Prednisone—prostate cancer	0.000165	0.000944	CcSEcCtD
Secobarbital—Phenobarbital—CYP3A4—prostate cancer	0.000161	0.0325	CrCbGaD
Secobarbital—Feeling abnormal—Epirubicin—prostate cancer	0.000161	0.00092	CcSEcCtD
Secobarbital—Somnolence—Doxorubicin—prostate cancer	0.000161	0.000919	CcSEcCtD
Secobarbital—Vomiting—Prednisone—prostate cancer	0.000159	0.000908	CcSEcCtD
Secobarbital—Rash—Prednisone—prostate cancer	0.000158	0.0009	CcSEcCtD
Secobarbital—Dermatitis—Prednisone—prostate cancer	0.000157	0.0009	CcSEcCtD
Secobarbital—Headache—Prednisone—prostate cancer	0.000157	0.000895	CcSEcCtD
Secobarbital—Constipation—Doxorubicin—prostate cancer	0.000155	0.000884	CcSEcCtD
Secobarbital—Body temperature increased—Epirubicin—prostate cancer	0.000155	0.000883	CcSEcCtD
Secobarbital—Feeling abnormal—Doxorubicin—prostate cancer	0.000149	0.000852	CcSEcCtD
Secobarbital—Nausea—Prednisone—prostate cancer	0.000148	0.000848	CcSEcCtD
Secobarbital—Hypersensitivity—Epirubicin—prostate cancer	0.000144	0.000823	CcSEcCtD
Secobarbital—Body temperature increased—Doxorubicin—prostate cancer	0.000143	0.000817	CcSEcCtD
Secobarbital—Hypersensitivity—Doxorubicin—prostate cancer	0.000133	0.000761	CcSEcCtD
Secobarbital—Dizziness—Epirubicin—prostate cancer	0.000129	0.000739	CcSEcCtD
Secobarbital—Vomiting—Epirubicin—prostate cancer	0.000124	0.00071	CcSEcCtD
Secobarbital—Rash—Epirubicin—prostate cancer	0.000123	0.000704	CcSEcCtD
Secobarbital—Dermatitis—Epirubicin—prostate cancer	0.000123	0.000704	CcSEcCtD
Secobarbital—Headache—Epirubicin—prostate cancer	0.000122	0.0007	CcSEcCtD
Secobarbital—Dizziness—Doxorubicin—prostate cancer	0.00012	0.000683	CcSEcCtD
Secobarbital—Nausea—Epirubicin—prostate cancer	0.000116	0.000663	CcSEcCtD
Secobarbital—Vomiting—Doxorubicin—prostate cancer	0.000115	0.000657	CcSEcCtD
Secobarbital—Rash—Doxorubicin—prostate cancer	0.000114	0.000652	CcSEcCtD
Secobarbital—Dermatitis—Doxorubicin—prostate cancer	0.000114	0.000651	CcSEcCtD
Secobarbital—Headache—Doxorubicin—prostate cancer	0.000113	0.000647	CcSEcCtD
Secobarbital—Nausea—Doxorubicin—prostate cancer	0.000107	0.000614	CcSEcCtD
Secobarbital—CYP2C8—Metabolism—TBXAS1—prostate cancer	1.43e-05	8.39e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA4—prostate cancer	1.43e-05	8.39e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ACSL4—prostate cancer	1.43e-05	8.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.43e-05	8.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.41e-05	8.28e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.4e-05	8.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA2—prostate cancer	1.39e-05	8.17e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCG5—prostate cancer	1.38e-05	8.07e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SULT1A1—prostate cancer	1.38e-05	8.07e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—UMPS—prostate cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ARG2—prostate cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PHGDH—prostate cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.36e-05	7.99e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.35e-05	7.91e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA1—prostate cancer	1.35e-05	7.88e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—LDHB—prostate cancer	1.34e-05	7.87e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTO1—prostate cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HSD3B2—prostate cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NAT2—prostate cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.32e-05	7.73e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.31e-05	7.7e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTAP—prostate cancer	1.31e-05	7.7e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.28e-05	7.52e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.28e-05	7.5e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.28e-05	7.5e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.28e-05	7.5e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PLCB2—prostate cancer	1.28e-05	7.47e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2C18—prostate cancer	1.28e-05	7.47e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—LRP2—prostate cancer	1.28e-05	7.47e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PDHA1—prostate cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—UCP3—prostate cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA3—prostate cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TCN2—prostate cancer	1.27e-05	7.46e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—P4HB—prostate cancer	1.25e-05	7.33e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.24e-05	7.28e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.22e-05	7.18e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ACSL4—prostate cancer	1.22e-05	7.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.22e-05	7.15e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC22A1—prostate cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HSD3B1—prostate cancer	1.22e-05	7.12e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC22A3—prostate cancer	1.22e-05	7.12e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.21e-05	7.07e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.2e-05	7.05e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SULT2A1—prostate cancer	1.19e-05	6.95e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.18e-05	6.91e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PHGDH—prostate cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—UMPS—prostate cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ARG2—prostate cancer	1.17e-05	6.86e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MED12—prostate cancer	1.17e-05	6.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.16e-05	6.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TBXAS1—prostate cancer	1.16e-05	6.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA4—prostate cancer	1.16e-05	6.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GNG5—prostate cancer	1.16e-05	6.78e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—LDHB—prostate cancer	1.15e-05	6.73e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.14e-05	6.67e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA2—prostate cancer	1.14e-05	6.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP3A5—prostate cancer	1.13e-05	6.6e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.12e-05	6.57e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCG5—prostate cancer	1.12e-05	6.57e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA3—prostate cancer	1.12e-05	6.53e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.1e-05	6.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA1—prostate cancer	1.1e-05	6.42e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—UCP3—prostate cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PDHA1—prostate cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA3—prostate cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TCN2—prostate cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HSD3B2—prostate cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NAT2—prostate cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTO1—prostate cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HPGDS—prostate cancer	1.06e-05	6.23e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2C19—prostate cancer	1.06e-05	6.19e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.04e-05	6.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC22A3—prostate cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HSD3B1—prostate cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLCB2—prostate cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—LRP2—prostate cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ACHE—prostate cancer	1.03e-05	6.05e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—prostate cancer	1.03e-05	6.05e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2A6—prostate cancer	1.02e-05	5.98e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—P4HB—prostate cancer	1.02e-05	5.97e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.02e-05	5.95e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.01e-05	5.9e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA4—prostate cancer	9.95e-06	5.83e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TBXAS1—prostate cancer	9.95e-06	5.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AKR1C3—prostate cancer	9.92e-06	5.81e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC22A1—prostate cancer	9.91e-06	5.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PRKACB—prostate cancer	9.87e-06	5.78e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.79e-06	5.74e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP17A1—prostate cancer	9.77e-06	5.72e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.73e-06	5.7e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA2—prostate cancer	9.7e-06	5.68e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SULT2A1—prostate cancer	9.65e-06	5.66e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.63e-06	5.64e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SULT1A1—prostate cancer	9.58e-06	5.61e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCG5—prostate cancer	9.58e-06	5.61e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MED12—prostate cancer	9.5e-06	5.56e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GNG5—prostate cancer	9.42e-06	5.52e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA1—prostate cancer	9.36e-06	5.48e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA2—prostate cancer	9.31e-06	5.45e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NAT2—prostate cancer	9.25e-06	5.42e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HSD3B2—prostate cancer	9.25e-06	5.42e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTO1—prostate cancer	9.25e-06	5.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA3—prostate cancer	9.08e-06	5.32e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.92e-06	5.23e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.9e-06	5.21e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SLC5A5—prostate cancer	8.88e-06	5.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLCB2—prostate cancer	8.87e-06	5.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—LRP2—prostate cancer	8.87e-06	5.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2C18—prostate cancer	8.87e-06	5.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—P4HB—prostate cancer	8.7e-06	5.1e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2E1—prostate cancer	8.67e-06	5.08e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HPGDS—prostate cancer	8.66e-06	5.07e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2C19—prostate cancer	8.6e-06	5.04e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NQO1—prostate cancer	8.57e-06	5.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC22A1—prostate cancer	8.46e-06	4.96e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TH—prostate cancer	8.45e-06	4.95e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ACHE—prostate cancer	8.4e-06	4.92e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—prostate cancer	8.4e-06	4.92e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.4e-06	4.92e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.37e-06	4.9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP3A4—prostate cancer	8.36e-06	4.9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.32e-06	4.87e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2A6—prostate cancer	8.3e-06	4.86e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	8.27e-06	4.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SULT2A1—prostate cancer	8.25e-06	4.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1B1—prostate cancer	8.22e-06	4.82e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MED12—prostate cancer	8.12e-06	4.75e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AKR1C3—prostate cancer	8.07e-06	4.73e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GNG5—prostate cancer	8.05e-06	4.72e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PRKACB—prostate cancer	8.03e-06	4.71e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GGT1—prostate cancer	7.96e-06	4.66e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP17A1—prostate cancer	7.95e-06	4.66e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA1—prostate cancer	7.84e-06	4.59e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.84e-06	4.59e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA3—prostate cancer	7.76e-06	4.54e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP19A1—prostate cancer	7.73e-06	4.53e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.62e-06	4.47e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA2—prostate cancer	7.57e-06	4.44e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—RXRA—prostate cancer	7.46e-06	4.37e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HPGDS—prostate cancer	7.4e-06	4.33e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2C19—prostate cancer	7.35e-06	4.31e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.26e-06	4.25e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SLC5A5—prostate cancer	7.23e-06	4.23e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—COMT—prostate cancer	7.19e-06	4.21e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—prostate cancer	7.18e-06	4.2e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ACHE—prostate cancer	7.18e-06	4.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—prostate cancer	7.15e-06	4.19e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2A6—prostate cancer	7.09e-06	4.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.07e-06	4.14e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2E1—prostate cancer	7.06e-06	4.14e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ITPR1—prostate cancer	7.04e-06	4.12e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NQO1—prostate cancer	6.98e-06	4.09e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.92e-06	4.05e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AKR1C3—prostate cancer	6.9e-06	4.04e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TH—prostate cancer	6.88e-06	4.03e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PRKACB—prostate cancer	6.86e-06	4.02e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.83e-06	4e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP3A4—prostate cancer	6.81e-06	3.99e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP17A1—prostate cancer	6.79e-06	3.98e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.77e-06	3.97e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.7e-06	3.93e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1B1—prostate cancer	6.69e-06	3.92e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TYMS—prostate cancer	6.65e-06	3.9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—prostate cancer	6.57e-06	3.85e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GGT1—prostate cancer	6.48e-06	3.8e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA2—prostate cancer	6.47e-06	3.79e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—LPL—prostate cancer	6.45e-06	3.78e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA1—prostate cancer	6.38e-06	3.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP19A1—prostate cancer	6.29e-06	3.69e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A1—prostate cancer	6.23e-06	3.65e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ERCC2—prostate cancer	6.18e-06	3.62e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SLC5A5—prostate cancer	6.17e-06	3.62e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—RXRA—prostate cancer	6.07e-06	3.56e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2E1—prostate cancer	6.03e-06	3.53e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NQO1—prostate cancer	5.96e-06	3.49e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.9e-06	3.46e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TH—prostate cancer	5.88e-06	3.44e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—COMT—prostate cancer	5.85e-06	3.43e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.84e-06	3.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—prostate cancer	5.82e-06	3.41e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP3A4—prostate cancer	5.82e-06	3.41e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTHFR—prostate cancer	5.81e-06	3.4e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.79e-06	3.39e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ITPR1—prostate cancer	5.73e-06	3.36e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1B1—prostate cancer	5.72e-06	3.35e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PPARA—prostate cancer	5.7e-06	3.34e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.63e-06	3.3e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GGT1—prostate cancer	5.54e-06	3.24e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA1—prostate cancer	5.45e-06	3.2e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TYMS—prostate cancer	5.41e-06	3.17e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP19A1—prostate cancer	5.38e-06	3.15e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CAV1—prostate cancer	5.36e-06	3.14e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—prostate cancer	5.35e-06	3.13e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—LPL—prostate cancer	5.25e-06	3.08e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—RXRA—prostate cancer	5.19e-06	3.04e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.12e-06	3e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A1—prostate cancer	5.07e-06	2.97e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.05e-06	2.96e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ERCC2—prostate cancer	5.03e-06	2.95e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—COMT—prostate cancer	5e-06	2.93e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—prostate cancer	4.97e-06	2.91e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ITPR1—prostate cancer	4.89e-06	2.87e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CG—prostate cancer	4.88e-06	2.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.81e-06	2.82e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTHFR—prostate cancer	4.73e-06	2.77e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PPARA—prostate cancer	4.64e-06	2.72e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TYMS—prostate cancer	4.62e-06	2.71e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—INS—prostate cancer	4.62e-06	2.71e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—prostate cancer	4.57e-06	2.68e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CREBBP—prostate cancer	4.52e-06	2.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—LPL—prostate cancer	4.49e-06	2.63e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CAV1—prostate cancer	4.36e-06	2.55e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1A1—prostate cancer	4.33e-06	2.54e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ERCC2—prostate cancer	4.3e-06	2.52e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CD—prostate cancer	4.29e-06	2.51e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.17e-06	2.44e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NOS3—prostate cancer	4.05e-06	2.37e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTHFR—prostate cancer	4.04e-06	2.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.97e-06	2.33e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PPARA—prostate cancer	3.96e-06	2.32e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—INS—prostate cancer	3.76e-06	2.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CB—prostate cancer	3.74e-06	2.19e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CAV1—prostate cancer	3.73e-06	2.18e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—prostate cancer	3.71e-06	2.17e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CREBBP—prostate cancer	3.68e-06	2.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.56e-06	2.09e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CD—prostate cancer	3.49e-06	2.05e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.39e-06	1.99e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NOS3—prostate cancer	3.3e-06	1.93e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTEN—prostate cancer	3.23e-06	1.89e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—INS—prostate cancer	3.21e-06	1.88e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CREBBP—prostate cancer	3.15e-06	1.84e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—EP300—prostate cancer	3.08e-06	1.81e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.04e-06	1.78e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—prostate cancer	3.02e-06	1.77e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.98e-06	1.75e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NOS3—prostate cancer	2.82e-06	1.65e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTEN—prostate cancer	2.63e-06	1.54e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.6e-06	1.52e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—prostate cancer	2.58e-06	1.51e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—EP300—prostate cancer	2.51e-06	1.47e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.28e-06	1.34e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTEN—prostate cancer	2.25e-06	1.32e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—EP300—prostate cancer	2.14e-06	1.26e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AKT1—prostate cancer	1.86e-06	1.09e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.86e-06	1.09e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.59e-06	9.29e-06	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AKT1—prostate cancer	1.52e-06	8.88e-06	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AKT1—prostate cancer	1.3e-06	7.59e-06	CbGpPWpGaD
